BACKGROUND: Subclinical hypothyroidism is a common thyroid disorder. Although there is a recognized association between thyroid disease and diabetes mellitus, there is no definite answer as to whether screening for subclinical hypothyroidism is necessary in patients with type 2 diabetes. The objective of the present study was to evaluate the prevalence of subclinical hypothyroidism in women with type 2 diabetes. MATERIAL/ METHODS: Four hundred ten women with type 2 diabetes (aged 59.6+/-10.9 years) and 125 women without diabetes (aged 51.8+/-15.8 years) were studied. Subclinical hypothyroidism was defined as a thyroid stimulating hormone level above the upper normal limit together and a normal free thyroxine level. Measurements of lipids, glycosylated hemoglobin, and antithyroid antibody levels were also performed. RESULTS: After excluding patients with previous thyroid disease, the prevalence of subclinical hypothyroidism was similar between patients with diabetes and control subjects (5.4% vs 7.9%, respectively) (P=0.32). When patients with known thyroid disease were included, the prevalence of subclinical hypothyroidism between groups was similar (9% in diabetes vs 8% in control subjects) (P=0.75). Across all participants, positivity for antithyroid antibody was significantly higher in patients with subclinical hypothyroidism than in euthyroid subjects. CONCLUSIONS: The similar prevalence of subclinical hypothyroidism in women with type 2 diabetes and women without diabetes suggests that routine screening of thyroid function in patients with type 2 diabetes is unwarranted.
BACKGROUND: Subclinical hypothyroidism is a common thyroid disorder. Although there is a recognized association between thyroid disease and diabetes mellitus, there is no definite answer as to whether screening for subclinical hypothyroidism is necessary in patients with type 2 diabetes. The objective of the present study was to evaluate the prevalence of subclinical hypothyroidism in women with type 2 diabetes. MATERIAL/ METHODS: Four hundred ten women with type 2 diabetes (aged 59.6+/-10.9 years) and 125 women without diabetes (aged 51.8+/-15.8 years) were studied. Subclinical hypothyroidism was defined as a thyroid stimulating hormone level above the upper normal limit together and a normal free thyroxine level. Measurements of lipids, glycosylated hemoglobin, and antithyroid antibody levels were also performed. RESULTS: After excluding patients with previous thyroid disease, the prevalence of subclinical hypothyroidism was similar between patients with diabetes and control subjects (5.4% vs 7.9%, respectively) (P=0.32). When patients with known thyroid disease were included, the prevalence of subclinical hypothyroidism between groups was similar (9% in diabetes vs 8% in control subjects) (P=0.75). Across all participants, positivity for antithyroid antibody was significantly higher in patients with subclinical hypothyroidism than in euthyroid subjects. CONCLUSIONS: The similar prevalence of subclinical hypothyroidism in women with type 2 diabetes and women without diabetes suggests that routine screening of thyroid function in patients with type 2 diabetes is unwarranted.
Authors: Sung Min Nam; Yo Na Kim; Dae Young Yoo; Sun Shin Yi; Woosuk Kim; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon Journal: Neurochem Res Date: 2011-10-30 Impact factor: 3.996
Authors: Rebecca J Ward; Adrian H Heald; Seyi Ogunmekan; Anthony A Fryer; Christopher J Duff Journal: Br J Gen Pract Date: 2018-02 Impact factor: 5.386
Authors: Jae Ho Cho; Ho Jin Kim; Jun Ho Lee; Il Rae Park; Jun Sung Moon; Ji Sung Yoon; In-Kyu Lee; Kyu Chang Won; Hyoung Woo Lee Journal: Korean J Intern Med Date: 2016-06-08 Impact factor: 2.884
Authors: Sung Min Nam; Yo Na Kim; Dae Young Yoo; Sun Shin Yi; Jung Hoon Choi; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon Journal: Neural Regen Res Date: 2013-09-15 Impact factor: 5.135